Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) Shares Shorted: Short Interest Up 330.6% in October

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) was the recipient of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 521 shares, a growth of 330.6% from the October 15th total of 121 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 3,288 shares, the days-to-cover ratio is presently 0.2 days.

Mosaic ImmunoEngineering Price Performance

Mosaic ImmunoEngineering stock opened at $0.06 on Friday. Mosaic ImmunoEngineering has a 52-week low of $0.05 and a 52-week high of $0.75. The company has a market cap of $434,400.00, a P/E ratio of -0.67 and a beta of -0.87. The business has a 50-day simple moving average of $0.13 and a two-hundred day simple moving average of $0.44.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.02) earnings per share for the quarter.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc. is a biotechnology company focused on developing immunotherapies designed to stimulate the body’s immune system to fight cancer. Its work has centered on therapeutic approaches intended to improve immune recognition and response against tumors. The company’s development activities have included DNA-based immunotherapy technology, including approaches designed to deliver immune-stimulating genetic material directly to tumor tissue. These therapies are intended to generate localized immune activation while supporting broader systemic anti-tumor responses.